Invention Grant
- Patent Title: Method for monitoring cancer and/or inflammatory reaction based on RelB phosphorylation
-
Application No.: US14784484Application Date: 2014-04-18
-
Publication No.: US09851363B2Publication Date: 2017-12-26
- Inventor: Veronique Baud , Katy Billot
- Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) , UNIVERSITE PARIS DESCARTES , INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
- Applicant Address: FR Paris FR Paris FR Paris
- Assignee: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS),UNIVERSITE PARIS DESCARTES,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
- Current Assignee: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS),UNIVERSITE PARIS DESCARTES,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
- Current Assignee Address: FR Paris FR Paris FR Paris
- Agency: Arrigo, Lee & Guttman LLP
- Priority: EP13305508 20130418
- International Application: PCT/EP2014/058021 WO 20140418
- International Announcement: WO2014/170487 WO 20141023
- Main IPC: G01N33/68
- IPC: G01N33/68 ; G01N33/574 ; C07K16/18

Abstract:
The present Inventors demonstrated that the RelB subunit of NFκB plays a crucial role in promoting cell migration. More precisely, they identified that this pro-migratory activity is mediated by the activation of the NFκB pathway through RelB phosphorylation at serine 472. In a first aspect, the present invention proposes to monitor the activation of the NFκB pathway by following the phosphorylation status of said serine. Also, the present invention discloses methods and kits for prognosing the evolution of a disease involving cell migration in a subject—treated or not—suffering thereof, based on the detection of said RelB-S472 phosphorylation.
Public/Granted literature
- US20160047821A1 METHOD FOR MONITORING CANCER AND/OR INFLAMMATORY REACTION BASED ON RELB PHOSPHORYLATION Public/Granted day:2016-02-18
Information query
IPC分类: